Therapix Biosciences Ltd Forecast and Stock Analysis
Technical TRPX stock analysis for February 14, 2019.
Therapix Biosciences Ltd fell by -5.45% in the last day from $4.18 to $3.95 The price has risen in 5 of the last 10 days and is up by 6.18% over the past 2 weeks. Volume has increased in the last day by 15 217 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 45 306 shares bought and sold for approximately $178 959.00.
Close price at the end of the last trading day (Thursday, 14th Feb 2019) of the TRPX stock was $3.95. This is 5.45% less than the trading day before Wednesday, 13th Feb 2019.
During day the stock fluctuated 11.14% from a day low at $3.95 to a day high of $4.39.
30 day high of the TRPX stock price was $5.15 and low was $3.40.
90 day high was $8.95 and low was $3.01.
52 week high for the Therapix Biosciences Ltd - $9.30 and low - $3.00.
Therapix Biosciences Ltd lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $4.12 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -45.71% during the next 3 months and, with 90% probability hold a price between $0.79 and $2.24 at the end of this period.
There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Wednesday February 13, 2019, which indicates further falls until a new bottom pivot has been found. Therapix Biosciences Ltd gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". Therapix Biosciences Ltd holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $4.00. On a fall, the stock will find some support from the long-term average at approximately $3.79. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.
Relative Strength Index (RSI)
RSI14 is 58 and the stock is currently not being overbought or oversold
Support & Resistance
Therapix Biosciences Ltd finds support from accumulated volume at $3.85.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.44 between high and low, or 11.14%. For the last week, the stock has had a daily average volatility of 7.71%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
Therapix Biosciences Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.